Abstract
The role of tissue transglutaminase (TG-2, TGase-2) in cancer development is still a fascinating field of research. The available reports do not elucidate fully its mechanism of action, due to the limitations of in vitro approaches. Therefore, to understand TG-2 role in cancer, we carried out an in vivo study with a more direct approach. TG-2 was in vivo overexpressed in a murine model of melanoma (intravenous injection of B16 melanoma cells in C57BL/6N mice) by means of a plasmid carrying the TG-2 cDNA. The evaluation of the frequency and size of the metastases indicated that the number of melanoma lung foci was more markedly reduced by TG-2 overexpression than the metastatic size. Then, TG-2 overexpressing mice showed a prolonged survival with respect to control mice. Further analyses were carried by means of proteomic analysis of melanoma cell lysates and meta-analysis of published transcriptomic datasets. Proteomic analysis of cell lysates from a human melanoma cell line compared to human keratinocytes showed significant differences in the expression of TG-2 substrates known to be involved in proliferation/differentiation and cancer progression. Taken together, these findings indicate a protective role of TG-2 enzymatic activity in melanoma progression in vivo.
Similar content being viewed by others
Abbreviations
- ASC:
-
Active site collection
- BAEC:
-
Bovine aortic endothelial cell
- CID:
-
Collision-induced dissociation
- DME:
-
Dulbecco’s modified Eagle medium
- ECM:
-
Extra-cellular matrix
- GI:
-
Growth index
- II:
-
Invasion index
- PAGE:
-
Polyacrylamide gel electrophoresis
- PBS:
-
Phosphate buffer solution
- RP-LC–MS/MS:
-
Reversed-phase liquid chromatography tandem mass spectrometry
- SDS:
-
Sodium dodecylsulfate
- TGase or TG:
-
Transglutaminase
- TRANSIT:
-
TRANSglutaminase SITes
References
Aguzzi MS, Facchiano F, Ribatti D, Gaeta R, Casadio R, Rossi I, Capogrossi MC, Facchiano A (2004) A novel RGDS-analog inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 321(4):809–814
Albini A, Iwamoto Y, Kleinman HK (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245
Beninati S (1995) Post-translational modification of protein in cancer cells: the transglutaminase-catalyzed reaction (editorial). Cancer J 8:234–236
Beninati S, Abbruzzese A, Cardinali M (1993) Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. Int J Cancer 53:792–797
Bergamini CM, Eckert RL, Ichinose A, Muszbek L, Squerzanti M (2003) Cellular differentiation and death in a renaissance castle. Cell Death Differ 10(2):262–265
Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN (2011) Combination of targeted therapy and immunotherapy in melanoma. Cancer Immunol Immunother 60(10):1359–1371
Brown ER, Doig T, Anderson N, Brenn T, Doherty V, Xu Y, Bartlett JM, Smyth JF, Melton DW (2012) Association of galectin-3 expression with melanoma progression and prognosis. Eur J Cancer 48(6):865–874
Chhabra A, Verma A, Mehta K (2009) Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 29(6):1909–1919
Di Giacomo G, Lentini A, Beninati S, Piacentini M, Rodolfo C (2009) In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma. Amino Acids 36(4):717–724
Facchiano A, Facchiano F (2009) Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 36(4):599–614
Facchiano F, D’Arcangelo D, Riccomi A, Lentini A, Beninati S, Capogrossi MC (2001) Transglutaminase activity is involved in polyamine-induced programmed cell death. Exp Cell Res 271(1):118–129
Facchiano AM, Facchiano A, Facchiano F (2003) Active sequences collection (ASC) database: a new tool to assign functions to protein sequences. Nucleic Acids Res 31(1):379–382
Facchiano F, Facchiano A, Facchiano AM (2006) The role of transglutaminase-2 and its substrates in human diseases. Front Biosci 11:1758–1773
Facchiano F, Deloye F, Doussau F, Innamorati G, Ashton AC, Dolly JO, Beninati S, Facchiano A, Luini A, Poulain B, Benfenati F (2010) Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function. Amino Acids 39(1):257–269
Fesus L (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett 328(1–2):1–5
Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534–539
Forni C, Braglia R, Lentini A, Nuccetelli M, Provenzano B, Tabolacci C, Beninati S (2009) Role of transglutaminase 2 in quercetin-induced differentiation of B16–F10 murine melanoma cells. Amino Acids 36(4):731–738
Gismondi A, Lentini A, Tabolacci C, Provenzano B, Beninati S (2010) Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16–F10 mouse melanoma cells. Amino Acids 38(1):257–262
Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5(15):3071–3077
Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368(Pt 2):377–396
Hong S, Hong S, Han B (2011) Overcoming metastatic melanoma with BRAF inhibitors. Arch Pharm Res 34(5):699–701
Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4(9):1265–1272
Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59:225
Knight CR, Rees RC, Griffin M (1991) Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta 1096(4):312–318
Lentini A, Vidal-Vanaclocha F, Facchiano F, Caraglia M, Abbruzzese A, Beninati S (2000a) Theophylline administration markedly reduces hepatic and pulmonary implantation of B16–F10 melanoma cells in mice. Melanoma Res 10(5):435–443
Lentini A, Autuori F, Mattioli P, Caraglia M, Abbruzzese A, Beninati S (2000b) Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 36(12):1572–1577
Lentini A, Provenzano B, Caraglia M, Shevchenko A, Abbruzzese A, Beninati S (2008) Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel. Amino Acids 34(2):251–256
Lentini A, Provenzano B, Tabolacci C, Beninati S (2009) Protein–polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids 36(4):701–708
Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET (2007) Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 82(3):364–380
Maurer G, Tarkowski B, Baccarini M (2011) Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 30(32):3477–3488
Mehta K, Kumar A, Kim HI (2010) Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80(12):1921–1929
Mycek MJ, Clarke DD, Neidle A, Waelsch H (1959) Amine incorporation into insulin as catalyzed by transglutaminase. Arch Biochem Biophys 84:528–540
Piacentini M, Martinet N, Beninati S, Folk JE (1988) Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem 263(8):3790–3794
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor
Singh RK, Liang D, Gajjalaiahvari UR, Kabbaj MH, Paik J, Gunjan A (2010) Excess histone levels mediate cytotoxicity via multiple mechanisms. Cell Cycle 9(20):4236–4244
Sosman JA, Puzanov I (2006) Molecular targets in melanoma from angiogenesis to apoptosis. Clin Cancer Res 12(7):2376s–2383s
Tabolacci C, Lentini A, Provenzano B, Beninati S (2012) Evidences for a role of protein cross-links in transglutaminase-related disease. Amino Acids 42:975–986
Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115(7):851–862
Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R (1979) Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777–785
Acknowledgments
The technology support from the Facility for Complex Protein Mixture (CPM) Analysis at ISS (Rome) and for Bioinformatics analysis at ISA-CNR (Avellino) and the financial support from the Italy-USA Oncoproteomic Program and Telethon-Italy (Grant GTF08002) are kindly acknowledged. The technical assistance from Dr. P. Pagnotto and Dr. M. Cordella are also acknowledged. S. Rossi was involved in the training program at the PhD. School (25° Ciclo) of Morphogenesis, Homeostasis and Tissue Engineering, Curriculum in Cell Sciences and Technologies, Sapienza University of Rome and C. Senatore in the training program at the PhD. School (25° Ciclo) of Human Pathology, Department of Experimental Medicine, Sapienza University of Rome.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Facchiano, F., D’Arcangelo, D., Lentini, A. et al. Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study. Amino Acids 44, 53–61 (2013). https://doi.org/10.1007/s00726-012-1351-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-012-1351-6